202 related articles for article (PubMed ID: 1682337)
1. Inactivation of HIV-1 by trypsin and its use in demonstrating specific virus infection of cells.
Tang SB; Levy JA
J Virol Methods; 1991 Jun; 33(1-2):39-46. PubMed ID: 1682337
[TBL] [Abstract][Full Text] [Related]
2. Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro.
McClure MO; Moore JP; Blanc DF; Scotting P; Cook GM; Keynes RJ; Weber JN; Davies D; Weiss RA
AIDS Res Hum Retroviruses; 1992 Jan; 8(1):19-26. PubMed ID: 1346567
[TBL] [Abstract][Full Text] [Related]
3. Curdlan sulfate and HIV-1. I. In vitro inhibitory effects of curdlan sulfate on HIV-1 infection.
Aoki T; Kaneko Y; Stefanski MS; Nguyen T; Ting RC
AIDS Res Hum Retroviruses; 1991 Apr; 7(4):409-15. PubMed ID: 1676899
[TBL] [Abstract][Full Text] [Related]
4. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines.
Patel M; Yanagishita M; Roderiquez G; Bou-Habib DC; Oravecz T; Hascall VC; Norcross MA
AIDS Res Hum Retroviruses; 1993 Feb; 9(2):167-74. PubMed ID: 8096145
[TBL] [Abstract][Full Text] [Related]
5. Binding of human immunodeficiency virus type-1 (HIV-1) to partially purified membrane vesicles of lymphoblastoid cell line CEM.
Benzair AB; Hirsch I; Chermann JC
J Virol Methods; 1993 Dec; 45(3):319-30. PubMed ID: 7508945
[TBL] [Abstract][Full Text] [Related]
6. MS-8209, a new Amphotericin B derivative that inhibits HIV-1 replication in vitro and restores T-cell activation via the CD3/TcR in HIV-infected CD4+ cells.
Céfai D; Hadida F; Jung M; Debre P; Vernin JG; Seman M
AIDS; 1991 Dec; 5(12):1453-61. PubMed ID: 1726040
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of HIV-1 cell binding and HIV-1-induced syncytium formation by low molecular weight sulphated polysaccharides.
Montefiori DC; Robinson WE; Modliszewski A; Rowland JM; Schuffman SS; Mitchell WM
J Antimicrob Chemother; 1990 Mar; 25(3):313-8. PubMed ID: 1692572
[TBL] [Abstract][Full Text] [Related]
8. Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells.
De Maria A; Pantaleo G; Schnittman SM; Greenhouse JJ; Baseler M; Orenstein JM; Fauci AS
J Immunol; 1991 Apr; 146(7):2220-6. PubMed ID: 1706390
[TBL] [Abstract][Full Text] [Related]
9. Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells.
Pope M; Gezelter S; Gallo N; Hoffman L; Steinman RM
J Exp Med; 1995 Dec; 182(6):2045-56. PubMed ID: 7500050
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies.
Zarling JM; Moran PA; Haffar O; Sias J; Richman DD; Spina CA; Myers DE; Kuebelbeck V; Ledbetter JA; Uckun FM
Nature; 1990 Sep; 347(6288):92-5. PubMed ID: 1975641
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of HIV-1 interactions with sCD4 and CD4+ cells: implications for inhibition of virus infection and initial steps of virus entry into cells.
Dimitrov DS; Willey RL; Martin MA; Blumenthal R
Virology; 1992 Apr; 187(2):398-406. PubMed ID: 1347667
[TBL] [Abstract][Full Text] [Related]
12. Reduction of human immunodeficiency virus production and cytopathic effects by inhibitors of the Na+/K+/2Cl- cotransporter.
Voss TG; Gatti PJ; Fermin CD; Garry RF
Virology; 1996 May; 219(1):291-4. PubMed ID: 8623543
[TBL] [Abstract][Full Text] [Related]
13. Effect of cytokines on HIV replication in CD4+ lymphocytes: lack of identity with the CD8+ cell antiviral factor.
Mackewicz CE; Ortega H; Levy JA
Cell Immunol; 1994 Feb; 153(2):329-43. PubMed ID: 7907003
[TBL] [Abstract][Full Text] [Related]
14. Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles.
Chimirri A; Grasso S; Monforte AM; Monforte P; Zappala M
Farmaco; 1991; 46(7-8):925-33. PubMed ID: 1686551
[TBL] [Abstract][Full Text] [Related]
15. Analysis of protein kinase C theta inhibitors for the control of HIV-1 replication in human CD4+ T cells reveals an effect on retrotranscription in addition to viral transcription.
Bermejo M; López-Huertas MR; Hedgpeth J; Mateos E; Rodríguez-Mora S; Maleno MJ; Plana M; Swindle J; Alcamí J; Coiras M
Biochem Pharmacol; 2015 Apr; 94(4):241-56. PubMed ID: 25732195
[TBL] [Abstract][Full Text] [Related]
16. Impaired immunity in AIDS. The mechanisms responsible and their potential reversal by antiviral therapy.
Ruegg CL; Engleman EG
Ann N Y Acad Sci; 1990; 616():307-17. PubMed ID: 1981824
[TBL] [Abstract][Full Text] [Related]
17. Rapid whole blood analysis of virus-specific CD4 and CD8 T cell responses in persistent HIV infection.
Sester M; Sester U; Köhler H; Schneider T; Deml L; Wagner R; Mueller-Lantzsch N; Pees HW; Meyerhans A
AIDS; 2000 Dec; 14(17):2653-60. PubMed ID: 11125883
[TBL] [Abstract][Full Text] [Related]
18. Role of CD4 in the penetration of cells by HIV.
McDougal JS; Maddon PJ; Orloff G; Clapham PR; Dalgleish AG; Jamal S; Weiss RA; Axel RA
Adv Exp Med Biol; 1991; 300():145-54; discussion 155-8. PubMed ID: 1685856
[No Abstract] [Full Text] [Related]
19. Establishment of an MT4 cell line persistently producing infective HIV-1 particles.
Gyuris A; Vajda G; Földes I
Acta Microbiol Hung; 1992; 39(3-4):271-9. PubMed ID: 1364232
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of the inhibitory effect of curdlan sulfate on HIV-1 infection in vitro.
Jagodzinski PP; Wiaderkiewicz R; Kurzawski G; Kloczewiak M; Nakashima H; Hyjek E; Yamamoto N; Uryu T; Kaneko Y; Posner MR
Virology; 1994 Aug; 202(2):735-45. PubMed ID: 7913276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
